IGFBP7 and acute myeloid leukemia: Importantly, in that study, 102 non-M3 AML patients with high IGFBP7 expression had better outcomes than patients with low IGFBP7 expression, indicating a positive role for IGFBP7 in the treatment and patient outcomes of AML.